Portfolio company
Precision Neuroscience
United States · £198m raised
Raised
£198m
Latest stage
Series B
Rounds recorded
1
Backed by
1 investor
Sectors
About
This company develops minimally invasive brain-computer interfaces for patients with neurological conditions such as paralysis, stroke, and traumatic brain injury.
SourceFunding history · 1
Similar companies
Precision Neuroscience
Precision Neuroscience develops minimally invasive brain-computer interfaces to help patients with paralysis and neurological disorders control digital devices using their thoughts.
Medical device company
Precision Neuroscience develops high-resolution cortical implants to restore functional independence for patients living with severe neurological conditions and physical disabilities.
Paradromics
This company develops implantable brain-computer interfaces to restore communication and computer control for patients with severe paralysis.
ABILITY Neurotech
This company develops fully implantable brain-computer interfaces to restore communication and movement for patients with severe neurological conditions including paralysis and ALS.
Neuralink
This company develops implantable brain-computer interfaces designed to help people with paralysis control digital devices using their thoughts.
Brain-to-Computer Interface
This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.
Echo Neurotechnologies
This company develops implantable brain-computer interfaces to restore conversational communication for patients with severe paralysis and speech disabilities.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
